BGI Genomics Statistics
Total Valuation
BGI Genomics has a market cap or net worth of CNY 19.60 billion. The enterprise value is 16.51 billion.
Market Cap | 19.60B |
Enterprise Value | 16.51B |
Important Dates
The last earnings date was Saturday, August 23, 2025.
Earnings Date | Aug 23, 2025 |
Ex-Dividend Date | Jul 4, 2024 |
Share Statistics
BGI Genomics has 383.85 million shares outstanding. The number of shares has decreased by -1.73% in one year.
Current Share Class | 383.85M |
Shares Outstanding | 383.85M |
Shares Change (YoY) | -1.73% |
Shares Change (QoQ) | +1.64% |
Owned by Insiders (%) | 1.10% |
Owned by Institutions (%) | 10.72% |
Float | 200.18M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 779.91 |
PS Ratio | 5.40 |
PB Ratio | 2.09 |
P/TBV Ratio | 2.21 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -18.04 |
EV / Sales | 4.55 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -20.06 |
Financial Position
The company has a current ratio of 2.81, with a Debt / Equity ratio of 0.09.
Current Ratio | 2.81 |
Quick Ratio | 2.50 |
Debt / Equity | 0.09 |
Debt / EBITDA | n/a |
Debt / FCF | -1.04 |
Interest Coverage | -27.96 |
Financial Efficiency
Return on equity (ROE) is -9.48% and return on invested capital (ROIC) is -5.02%.
Return on Equity (ROE) | -9.48% |
Return on Assets (ROA) | -4.05% |
Return on Invested Capital (ROIC) | -5.02% |
Return on Capital Employed (ROCE) | -8.32% |
Revenue Per Employee | 979,725 |
Profits Per Employee | -247,194 |
Employee Count | 3,702 |
Asset Turnover | 0.28 |
Inventory Turnover | 3.92 |
Taxes
In the past 12 months, BGI Genomics has paid 3.35 million in taxes.
Income Tax | 3.35M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +44.89% in the last 52 weeks. The beta is 0.74, so BGI Genomics's price volatility has been lower than the market average.
Beta (5Y) | 0.74 |
52-Week Price Change | +44.89% |
50-Day Moving Average | 51.70 |
200-Day Moving Average | 50.51 |
Relative Strength Index (RSI) | 43.89 |
Average Volume (20 Days) | 9,556,698 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BGI Genomics had revenue of CNY 3.63 billion and -915.11 million in losses. Loss per share was -2.23.
Revenue | 3.63B |
Gross Profit | 1.34B |
Operating Income | -838.16M |
Pretax Income | -924.76M |
Net Income | -915.11M |
EBITDA | -424.06M |
EBIT | -838.16M |
Loss Per Share | -2.23 |
Balance Sheet
The company has 4.08 billion in cash and 853.84 million in debt, giving a net cash position of 3.23 billion or 8.41 per share.
Cash & Cash Equivalents | 4.08B |
Total Debt | 853.84M |
Net Cash | 3.23B |
Net Cash Per Share | 8.41 |
Equity (Book Value) | 9.39B |
Book Value Per Share | 22.08 |
Working Capital | 4.37B |
Cash Flow
In the last 12 months, operating cash flow was -237.64 million and capital expenditures -585.27 million, giving a free cash flow of -822.91 million.
Operating Cash Flow | -237.64M |
Capital Expenditures | -585.27M |
Free Cash Flow | -822.91M |
FCF Per Share | -2.14 |
Margins
Gross margin is 37.03%, with operating and profit margins of -23.11% and -25.23%.
Gross Margin | 37.03% |
Operating Margin | -23.11% |
Pretax Margin | -25.50% |
Profit Margin | -25.23% |
EBITDA Margin | -11.69% |
EBIT Margin | -23.11% |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.10, which amounts to a dividend yield of 0.20%.
Dividend Per Share | 0.10 |
Dividend Yield | 0.20% |
Dividend Growth (YoY) | -90.00% |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 1.73% |
Shareholder Yield | 1.92% |
Earnings Yield | -4.67% |
FCF Yield | -4.20% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
BGI Genomics has an Altman Z-Score of 4.32 and a Piotroski F-Score of 2.
Altman Z-Score | 4.32 |
Piotroski F-Score | 2 |